|Welcome to Mediscript: Providing innovation, imagination, inspiration and integrity|
The 17th Annual Resistance and Antiviral Therapy Meeting was held at the Royal College of Physicians in London on Tuesday 1 October 2013. Our international speakers included Professor Stuart Ray, Dr Federico Garcia, Professor Linos Vandekerckhove, Dr Richard Barnard, and Dr Anne-Geneviève Marcelin.
Delegate feedback reported that the programme was intellectually stimulating and enjoyable. In total 130 delegates attended the conference. This number included 5 student scholarship winners and 1 community registration place.
The Review Session
Understanding hepatitis C infection: virological and immunological determinants of disease outcomes
Perspectives on hepatitis C treatment in the context of HIV infection: looking ahead
Tools to monitor HIV infection in 2013 and beyond
Detecting HIV persistence during antiretroviral therapy
HIV eradication: what is likely to work?
Five papers that will change clinical practice
HIV prevention strategies: how well do they work?
The UK Collaborative Group on HIV Drug Resistance Abstract Presentation Session
Abstract presentations 1–3
Determinants of presence of NNRTI resistance mutations after interrupting or stopping ART which contained an NNRTI
Genetic diversity of HIV in the UK
Update on impact of RT polymorphisms on NNRTI-based ART
The Clinical Care Session
Resistance to novel integrase inhibitors
Rilpivirine: when to use, when not
Continuing Professional Development (CPD)
Medical staff in career-grade posts who are enrolled with one of the Federation of Royal Colleges for Continuing Professional Development can receive CPD credits at the rate of one CPD credit per hour (exclusive of travel, refreshments or social activities). The conference has been allocated 6 CPD credits with the unique reference code: 83868. Certificates for attendance were supplied in the conference pack that was handed to you at the registration desk.